What is Rimegepant Rimegepant is an oral calcitonin gene-related peptide (CGRP) receptor antagonist indicated for the acute treatment of migraine with or without aura in adults. Rimegepant is not indicated for the preventative treatment of migraine. In a randomized, double-blind, placebo-controlled trial, significantly more patients were pain free at 2 hours post-dose with rimegepant 75 …
What is Rimantadine Rimantadine is an oral antiviral agent indicated for the prophylaxis and treatment of seasonal influenza A virus infections in adults and for prophylaxis only in children. Rimantadine is chemically and structurally related to amantadine, but rimantadine lacks the central nervous system effects seen with amantadine. These 2 drugs differ significantly in their …
What is RimabotulinumtoxinB RimabotulinumtoxinB (formerly known as botulinum toxin type B) is a botulinum toxin produced from fermentation of Clostridium botulinum type B. RimabotulinumtoxinB is approved for treating cervical dystonia and chronic sialorrhea in adults. It decreases the severity of abnormal head position and neck pain in patients with cervical dystonia, and it has been found effective …
What is Riluzole Riluzole is an oral glutamate antagonist approved for the treatment of amyotrophic lateral sclerosis (ALS). Riluzole does not cure the disease or improve symptoms, but it might prolong the survival of patients by approximately 3 months. Riluzole appears to be more effective in patients with bulbar-onset disease than for those with limb-onset …
What is Rilpivirine Rilpivirine is an oral, diarylpyrimidine, non-nucleoside reverse transcriptase inhibitor (NNRTI). It is indicated for use with other antiretroviral agents to treat HIV-1 infection in antiretroviral treatment-naive patients 12 years and older and weight at least 35 kg with HIV-1 RNA concentrations of 100,000 copies/mL or less at initiation of therapy. Brand Name …
What is Rilonacept Rilonacept (Arcalyst™, Interleukin-1 Trap) is an interleukin-1 inhibitor that is the first FDA-approved treatment for cryopyrin-associated periodic syndromes (CAPS) including familial cold autoinflammatory syndrome (FCAS) and Muckle-Wells syndrome (MWS) in adults and children at least 12 years of age. Cryopyrin-associated periodic syndromes is a spectrum of rare, inherited autoinflammatory conditions. The autoinflammatory …
What is Rifaximin Rifaximin (Xifaxan) is an oral rifamycin antibiotic structurally related to rifampin. The drug is indicated to treat patients with traveler’s diarrhea caused by noninvasive strains of Escherichia coli, irritable bowel syndrome with diarrhea, and to reduce the risk of hepatic encephalopathy recurrence. The antimicrobial spectrum of activity includes various gram-positive and gram-negative aerobes …